...
首页> 外文期刊>The Journal of Nutritional Biochemistry >K16-biotinylated histone H4 is overrepresented in repeat regions and participates in the repression of transcriptionally competent genes in human Jurkat lymphoid cells
【24h】

K16-biotinylated histone H4 is overrepresented in repeat regions and participates in the repression of transcriptionally competent genes in human Jurkat lymphoid cells

机译:K16生物素化的组蛋白H4在重复区域中过量表达,并参与人Jurkat淋巴样细胞中转录能力基因的抑制

获取原文
获取原文并翻译 | 示例
           

摘要

Holocarboxylase synthetase (HCS) catalyzes the binding of biotin to lysine (K) residues in histones H3 and H4. Histone biotinylation marks are enriched in repressed loci, including retrotransposons. Preliminary studies suggested that K16 in histone H4 is a target for biotinylation by HCS. Here we tested the hypotheses that H4K16bio is a real histone mark in human chromatin and that H4K16bio is overrepresented in repressed gene loci and repeat regions. Polyclonal rabbit anti-human H4K16bio was generated and affinity purified. An extensive series of testing with synthetic and natural targets confirmed that this new antibody is specific for H4K16bio. Using anti-H4K16bio and chromatin immunoprecipitation assays, we demonstrated that H4K16bio is overrepresented in repeat regions [pericentromeric alpha satellite repeats and long terminal repeats (LTR)] compared with euchromatin promoters. H4K16bio was also enriched in the repressed interleukin-2 gene promoter in human lymphoid cells; transcriptional activation of the interleukin-2 gene by mitogens and phorbol esters coincided with a depletion of the H4K16bio mark at the gene promoter. The enrichment of H4K16bio depended on biotin supply; the enrichment at LTR22 and promoter 1 of the sodium-dependent multivitamin transporter (SMVT) was greater in biotin-supplemented cells compared with biotin-normal and biotin-deficient cells. The enrichment of H4K16bio at LTR15 and SMVT promoter 1 was significantly lower in fibroblasts from an HCS-deficient patient compared with an HCS wild-type control. We conclude that H4K16bio is a real phenomenon and that this mark, like other biotinylation marks, is overrepresented in repressed loci where it marks HCS docking sites.
机译:全息羧化酶合成酶(HCS)催化生物素与组蛋白H3和H4中赖氨酸(K)残基的结合。组蛋白的生物素化标记富含被抑制的基因座,包括逆转座子。初步研究表明,组蛋白H4中的K16是HCS进行生物素化的目标。在这里,我们测试了H4K16bio是人类染色质中真正的组蛋白标记,并且H4K16bio在受压基因位点和重复区域中过分表达的假设。产生多克隆兔抗人H4K16bio,并亲和纯化。使用合成靶标和天然靶标进行的广泛测试证实了这种新抗体对H4K16bio具有特异性。使用抗H4K16bio和染色质免疫沉淀测定法,我们证明了与正常染色质启动子相比,H4K16bio在重复区域[perenentromeric alpha卫星重复和长末端重复(LTR)]中过分表达。 H4K16bio还富含人淋巴样细胞中被抑制的白介素2基因启动子。有丝分裂原和佛波酯对白介素2基因的转录激活与基因启动子处H4K16bio标记的耗尽相吻合。 H4K16bio的富集取决于生物素的供应。与正常的生物素和缺乏生物素的细胞相比,补充生物素的细胞在LTR22和钠依赖性多种维生素转运蛋白(SMVT)的启动子1处的富集更大。与HCS野生型对照相比,来自HCS缺乏患者的成纤维细胞中LTR15和SMVT启动子1的H4K16bio富集显着降低。我们得出的结论是,H4K16bio是一种真实的现象,并且与其他生物素化标记一样,该标记在其标记为HCS停靠位点的受抑制基因座中也过分表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号